Valproate therapy for prevention of posttraumatic seizures: a randomized trial

View More View Less
  • 1 Departments of Neurological Surgery, Biostatistics, Rehabilitation Medicine, Pharmacy, Neurology, and Radiology, University of Washington, Seattle, Washington
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object. Seizures frequently accompany moderate to severe traumatic brain injury. Phenytoin and carbamazepine are effective in preventing early, but not late, posttraumatic seizures. In this study the authors compare the safety and effectiveness of valproate with those of short-term phenytoin for prevention of seizures following traumatic brain injury.

Methods. The study was a randomized, double-blind, single-center, parallel-group clinical trial. Treatment began within 24 hours of injury. One hundred thirty-two patients at high risk for seizures were assigned to receive a 1-week course of phenytoin, 120 were assigned to receive a 1-month course of valproate, and 127 were assigned to receive a 6-month course of valproate. The cases were followed for up to 2 years.

The rates of early seizures were low and similar when using either valproate or phenytoin (1.5% in the phenytoin treatment group and 4.5% in the valproate arms of the study; p = 0.14, relative risk [RR] = 2.9, 95% confidence interval [CI] 0.7–13.3). The rates of late seizures did not differ among treatment groups (15% in patients receiving the 1-week course of phenytoin, 16% in patients receiving the 1-month course of valproate, and 24% in those receiving the 6-month course of valproate; p = 0.19, RR = 1.4, 95% CI 0.8–2.4). The rates of mortality were not significantly different between treatment groups, but there was a trend toward a higher mortality rate in patients treated with valproate (7.2% in patients receiving phenytoin and 13.4% in those receiving valproate; p = 0.07, RR = 2.0, 95% CI 0.9–4.1). The incidence of serious adverse events, including coagulation problems and liver abnormalities, was similar in phenytoin- and valproate-treated patients.

Conclusions. Valproate therapy shows no benefit over short-term phenytoin therapy for prevention of early seizures and neither treatment prevents late seizures. There was a trend toward a higher mortality rate among valproate-treated patients. The lack of additional benefit and the potentially higher mortality rate suggest that valproate should not be routinely used for the prevention of posttraumatic seizures.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address reprint requests to: Nancy R. Temkin, Ph.D., Department of Neurological Surgery, University of Washington, Box 359924, Harborview Medical Center, 325 9th Avenue, Seattle, Washington 98104–2499. email: temkin@biostat.washington.edu.
  • 1.

    Applegate CD, , Samorski GM, & Özduman K: Effects of valproate, phenytoin, and MK-801 in a novel model of epileptogenesis. Epilepsia 38:631636, 1997 Applegate CD, Samorski GM, Özduman K: Effects of valproate, phenytoin, and MK-801 in a novel model of epileptogenesis. Epilepsia 38:631–636, 1997

    • Search Google Scholar
    • Export Citation
  • 2.

    Barr RD, , Copeland SA, & Stockwell ML, et al: Valproic acid and immune thrombocytopenia. Arch Dis Child 57:681684, 1982 Barr RD, Copeland SA, Stockwell ML, et al: Valproic acid and immune thrombocytopenia. Arch Dis Child 57:681–684, 1982

    • Search Google Scholar
    • Export Citation
  • 3.

    Birkmayer W: Die Behandlung der traumatischen Epilepsie. Wien Klin Wochenschr 63:603609, 1951 Birkmayer W: Die Behandlung der traumatischen Epilepsie. Wien Klin Wochenschr 63:603–609, 1951

    • Search Google Scholar
    • Export Citation
  • 4.

    Dikmen S, , Machamer J, & Savoie T, et al: Life quality outcome in head injury, in Grant I, & Adams KM (eds): Neuropsychological Assessment of Neuropsychiatric Disorders, ed 2. New York: Oxford University Press, 1996, pp 552576 Dikmen S, Machamer J, Savoie T, et al: Life quality outcome in head injury, in Grant I, Adams KM (eds): Neuropsychological Assessment of Neuropsychiatric Disorders, ed 2. New York: Oxford University Press, 1996, pp 552–576

    • Search Google Scholar
    • Export Citation
  • 5.

    Dikmen S, & Machamer JE: Neurobehavioral outcomes and their determinants. J Head Trauma Rehabil 10:7486, 1995 Dikmen S, Machamer JE: Neurobehavioral outcomes and their determinants. J Head Trauma Rehabil 10:74–86, 1995

    • Search Google Scholar
    • Export Citation
  • 6.

    Dreifuss FE, , Langer DH, & Moline KA, et al: Valproic acid hepatic fatalities, II. US experience since 1984. Neurology 39:201207, 1989 Dreifuss FE, Langer DH, Moline KA, et al: Valproic acid hepatic fatalities, II. US experience since 1984. Neurology 39:201–207, 1989

    • Search Google Scholar
    • Export Citation
  • 7.

    Dreifuss FE, , Santilli N, & Langer DH, et al: Valproic acid hepatic fatalities: a retrospective review. Neurology 37:379385, 1987 Dreifuss FE, Santilli N, Langer DH, et al: Valproic acid hepatic fatalities: a retrospective review. Neurology 37:379–385, 1987

    • Search Google Scholar
    • Export Citation
  • 8.

    Ganick DJ, , Sunder T, & Finley JL: Severe hematologic toxicity of valproic acid. A report of four patients. Am J Pediatr Hematol Oncol 12:8085, 1990 Ganick DJ, Sunder T, Finley JL: Severe hematologic toxicity of valproic acid. A report of four patients. Am J Pediatr Hematol Oncol 12:80–85, 1990

    • Search Google Scholar
    • Export Citation
  • 9.

    Glötzner FL, , Haubitz I, & Miltner F, et al: Anfallsprophylaxe mit Carbamazepin nach schweren Schädelhirnverletzungen. Neurochirurgia 26:6679, 1983 Glötzner FL, Haubitz I, Miltner F, et al: Anfallsprophylaxe mit Carbamazepin nach schweren Schädelhirnverletzungen. Neurochirurgia 26:66–79, 1983

    • Search Google Scholar
    • Export Citation
  • 10.

    Hoff H, & Hoff H: Fortrschritte in der Behandlung der Epilepsie. Mschr Psychiat Neurol 114:105118, 1947 Hoff H, Hoff H: Fortrschritte in der Behandlung der Epilepsie. Mschr Psychiat Neurol 114:105–118, 1947

    • Search Google Scholar
    • Export Citation
  • 11.

    Jennett B, & Teasdale G: Management of Head Injuries. Philadelphia: FA Davis, 1981 Jennett B, Teasdale G: Management of Head Injuries. Philadelphia: FA Davis, 1981

    • Search Google Scholar
    • Export Citation
  • 12.

    Klauber MR, , Marshall LF, & Luersen TG, et al: Determinants of head injury mortality: importance of the low risk patient. Neurosurgery 24:3136, 1989 Klauber MR, Marshall LF, Luersen TG, et al: Determinants of head injury mortality: importance of the low risk patient. Neurosurgery 24:31–36, 1989

    • Search Google Scholar
    • Export Citation
  • 13.

    Kraus JF, , Black MA, & Hessol N, et al: The incidence of acute brain injury and serious impairment in a defined population. Am J Epidemiol 119:186201, 1984 Kraus JF, Black MA, Hessol N, et al: The incidence of acute brain injury and serious impairment in a defined population. Am J Epidemiol 119:186–201, 1984

    • Search Google Scholar
    • Export Citation
  • 14.

    Lockard JS, , DuCharme LL, & Congdon WC, et al: Prophylaxis with diphenylhydantoin and phenobarbital in alumina-gel monkey model. II. Four-month follow-up period: seizure, EEG, blood, and behavioral data. Epilepsia 17:4957, 1976 Lockard JS, DuCharme LL, Congdon WC, et al: Prophylaxis with diphenylhydantoin and phenobarbital in alumina-gel monkey model. II. Four-month follow-up period: seizure, EEG, blood, and behavioral data. Epilepsia 17:49–57, 1976

    • Search Google Scholar
    • Export Citation
  • 15.

    Loiseau P: Sodium valproate, platelet dysfunction, and bleeding. Epilepsia 22:141146, 1981 Loiseau P: Sodium valproate, platelet dysfunction, and bleeding. Epilepsia 22:141–146, 1981

    • Search Google Scholar
    • Export Citation
  • 16.

    Marshall LF, , Gautille T, & Klauber MR, et al: The outcome of severe closed head injury. J Neurosurg 75 (Suppl):S28S36, 1991 Marshall LF, Gautille T, Klauber MR, et al: The outcome of severe closed head injury. J Neurosurg 75 (Suppl):S28–S36, 1991

    • Search Google Scholar
    • Export Citation
  • 17.

    Marshall LF, , Marshall SB, & Klauber MR, et al: The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma 9 (Suppl 1):S287S292, 1992 Marshall LF, Marshall SB, Klauber MR, et al: The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma 9 (Suppl 1):S287–S292, 1992

    • Search Google Scholar
    • Export Citation
  • 18.

    McNamara JO, , Russell RD, & Rigsbee L, et al: Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models. Neuropharmacology 27:563568, 1988 McNamara JO, Russell RD, Rigsbee L, et al: Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models. Neuropharmacology 27:563–568, 1988

    • Search Google Scholar
    • Export Citation
  • 19.

    Pechadre JC, , Lauxerois M, & Colnet G, et al: Prévention de l' épilepsie post-traumatique tardive par phénytoïne dans les traumatismes crâniens graves. Suivi durant 2 ans. Presse Med 20:841845, 1991 Pechadre JC, Lauxerois M, Colnet G, et al: Prévention de l' épilepsie post-traumatique tardive par phénytoïne dans les traumatismes crâniens graves. Suivi durant 2 ans. Presse Med 20:841–845, 1991

    • Search Google Scholar
    • Export Citation
  • 20.

    Penry JK, , White BG, & Brackett CE: A controlled prospective study of the pharmacologic prophylaxis of posttraumatic epilepsy. Neurology 29:600601, 1979 (Abstract) Penry JK, White BG, Brackett CE: A controlled prospective study of the pharmacologic prophylaxis of posttraumatic epilepsy. Neurology 29:600–601, 1979 (Abstract)

    • Search Google Scholar
    • Export Citation
  • 21.

    Racine RJ, , Livingston K, & Joaquin A: Effects of procaine hydrochloride, diazepam and diphenylhydantoin on seizure development in cortical and subcortical structures in rat. Electroencephalogr Clin Neurophysiol 38:355365, 1975 Racine RJ, Livingston K, Joaquin A: Effects of procaine hydrochloride, diazepam and diphenylhydantoin on seizure development in cortical and subcortical structures in rat. Electroencephalogr Clin Neurophysiol 38:355–365, 1975

    • Search Google Scholar
    • Export Citation
  • 22.

    Ranganathan C, , Verma NP, & Diaz FG: Valproate and epilepsy surgery. J Epilepsy 6:142144, 1993 Ranganathan C, Verma NP, Diaz FG: Valproate and epilepsy surgery. J Epilepsy 6:142–144, 1993

    • Search Google Scholar
    • Export Citation
  • 23.

    Scheffner D, , König S, & Rauterberg-Ruland I, et al: Fatal liver failure in 16 children with valproate therapy. Epilepsia 29:530542, 1988 Scheffner D, König S, Rauterberg-Ruland I, et al: Fatal liver failure in 16 children with valproate therapy. Epilepsia 29:530–542, 1988

    • Search Google Scholar
    • Export Citation
  • 24.

    Schmutz M, , Klebs K, & Baltzer V: Inhibition or enhancement of kindling evolution by antiepileptics. J Neural Transm 72:245257, 1988 Schmutz M, Klebs K, Baltzer V: Inhibition or enhancement of kindling evolution by antiepileptics. J Neural Transm 72:245–257, 1988

    • Search Google Scholar
    • Export Citation
  • 25.

    Silver JM, , Shin C, & McNamara JO: Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann Neurol 29:356363, 1991 Silver JM, Shin C, McNamara JO: Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann Neurol 29:356–363, 1991

    • Search Google Scholar
    • Export Citation
  • 26.

    Smith FR, & Boots M: Sodium valproate and bone marrow suppression. Ann Neurol 8:197199, 1980 Smith FR, Boots M: Sodium valproate and bone marrow suppression. Ann Neurol 8:197–199, 1980

    • Search Google Scholar
    • Export Citation
  • 27.

    Temkin NR, , Dikmen SS, & Wilensky AJ, et al: A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 323:497502, 1990 Temkin NR, Dikmen SS, Wilensky AJ, et al: A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 323:497–502, 1990

    • Search Google Scholar
    • Export Citation
  • 28.

    Temkin NR, , Haglund MM, & Winn HR: Post-traumatic seizures, in Youmans JR (ed): Neurological Surgery, ed 4. Philadelphia: WB Saunders, 1996, Vol 3, pp 18341839 Temkin NR, Haglund MM, Winn HR: Post-traumatic seizures, in Youmans JR (ed): Neurological Surgery, ed 4. Philadelphia: WB Saunders, 1996, Vol 3, pp 1834–1839

    • Search Google Scholar
    • Export Citation
  • 29.

    Wada JA, , Sato M, & Wake A: Prophylactic effects of phenytoin, phenobarbital and carbamazepine examined in kindling cat preparations. Arch Neurol 33:426434, 1976 Wada JA, Sato M, Wake A: Prophylactic effects of phenytoin, phenobarbital and carbamazepine examined in kindling cat preparations. Arch Neurol 33:426–434, 1976

    • Search Google Scholar
    • Export Citation
  • 30.

    Young B, , Rapp RP, & Norton JA, et al: Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures. J Neurosurg 58:231235, 1983 Young B, Rapp RP, Norton JA, et al: Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures. J Neurosurg 58:231–235, 1983

    • Search Google Scholar
    • Export Citation
  • 31.

    Young B, , Rapp RP, & Norton JA, et al: Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures. J Neurosurg 58:236241, 1983 Young B, Rapp RP, Norton JA, et al: Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures. J Neurosurg 58:236–241, 1983

    • Search Google Scholar
    • Export Citation

Metrics